About QED Bioscience
QED Bioscience is a company based in San Diego (United States) founded in 1997 was acquired by Leinco Technologies in September 2024. The company has 6 employees as of December 31, 2018. QED Bioscience operates in a competitive market with competitors including GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
- Headquarter San Diego, United States
- Employees 6 as on 31 Dec, 2018
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Qed Bioscience, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Genovis
& 1 more
-
Employee Count
6
as on Dec 31, 2018
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of QED Bioscience
Detailed funding history for QED Bioscience
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in QED Bioscience
QED Bioscience has secured backing from 2 investors. Prominent investors backing the company include Genovis and Leinco Technologies.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Enzymes for monoclonal antibody characterization are developed.
|
Locked | Locked | Locked | |
|
Manufacturer of antibodies, proteins, reagents, and kits for life science research
|
Locked | Locked | Locked |
Investor details for QED Bioscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by QED Bioscience
Investment portfolio details for QED Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - QED Bioscience
Detailed financials for QED Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Qed Bioscience Comparisons
Peer comparison for QED Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of QED Bioscience
QED Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Monoclonal antibody technology and products are developed by Epitomics.
|
|
| Locked | Locked | Locked |
Developer of antibodies for the treatment of multiple diseases
|
|
| Locked | Locked | Locked |
Antibodies and immunoassay kits are developed for research applications.
|
|
| Locked | Locked | Locked |
Antibody and vaccine culture media products are developed.
|
Detailed competitors of QED Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Qed Bioscience
Complete news archive for QED Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about QED Bioscience
QED Bioscience was founded in 1997.
QED Bioscience is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
As of Dec 31, 2018, the latest employee count at QED Bioscience is 6.
QED Bioscience manufactures a wide range of monoclonal and polyclonal antibodies, recombinant proteins and assay kits for life science research. The company also provides custom antibody development, purification and production, and cell culture services.
QED Bioscience's top competitors include Sino Biological, GenScript and Y-Biologics.
QED Bioscience has 2 investors. Key investors include Genovis, and Leinco Technologies.